Home › Funds › FRONTIER CAPITAL MANAGEMENT CO LLC › JAZZ

FRONTIER CAPITAL MANAGEMENT CO LLC position in JAZZ

JAZZ PHARMACEUTICALS PLC · Health Care

FRONTIER CAPITAL MANAGEMENT CO LLC reported holding 336,709 shares of JAZZ (JAZZ PHARMACEUTICALS PLC) in its Q3 2026 13F filing — a position valued at US$78.0M, representing 0.83% of its reported portfolio and ranking #23 among its reported holdings. FRONTIER CAPITAL MANAGEMENT CO LLC has disclosed JAZZ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)336.71K sh
Reported value held$77.95M
Portfolio Weight0.83%
First reportedQ3 2023
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How FRONTIER CAPITAL MANAGEMENT CO LLC's JAZZ position evolved

FRONTIER CAPITAL MANAGEMENT CO LLC first disclosed a stake in JAZZ in Q3 2023 at 58,467 shares (US$7.6M). The position peaked in Q1 2026 at 517,284 shares, worth US$97.8M. Across 13 filings, FRONTIER CAPITAL MANAGEMENT CO LLC increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 336,709 shares valued at US$78.0M — an increase of 59,430 shares quarter over quarter.. Notable position changes include a 373% increase in Q4 2025 (shares rose 11% over the following quarter), a 184% increase in Q1 2026 (shares rose 27% over the following quarter), a 46% trim in Q2 2026 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 58.47K $7.57M New
Q4 2023 59.84K $7.36M Add
Q1 2024 33.25K $4.00M Reduce
Q2 2024 24.42K $2.61M Reduce
Q3 2024 23.98K $2.67M Reduce
Q4 2024 35.00K $4.31M Add
Q1 2025 39.79K $4.94M Add
Q2 2025 39.67K $4.21M Hold
Q3 2025 38.51K $5.08M Reduce
Q4 2025 182.20K $30.97M Add
Q1 2026 517.28K $97.79M Add
Q2 2026 277.28K $66.82M Reduce
Q3 2026 336.71K $77.95M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JAZZ and 13F data

JAZZ (JAZZ PHARMACEUTICALS PLC) is a Health Care company. 41 other funds we track also report a position in JAZZ — the largest reported positions include FULLER & THALER ASSET MANAGEMENT, INC. (US$323.8M), Boston Trust Walden Corp (US$98.3M), Sofinnova Investments, Inc. (US$97.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JAZZ

All JAZZ fund holders →

FAQ

How long has FRONTIER CAPITAL MANAGEMENT CO LLC held JAZZ?

FRONTIER CAPITAL MANAGEMENT CO LLC has disclosed JAZZ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is FRONTIER CAPITAL MANAGEMENT CO LLC's current position in JAZZ?

As of Q3 2026, FRONTIER CAPITAL MANAGEMENT CO LLC holds 336.71K shares of JAZZ (JAZZ PHARMACEUTICALS PLC), valued at $77.95M, representing 0.83% of its reported portfolio and ranking #23.

Has FRONTIER CAPITAL MANAGEMENT CO LLC been buying or selling JAZZ?

In the latest 13F filing (Q3 2026), FRONTIER CAPITAL MANAGEMENT CO LLC increased its position in JAZZ. The position peaked in Q1 2026 at 517.28K shares.

Which other funds hold JAZZ?

Other major institutional holders of JAZZ include FULLER & THALER ASSET MANAGEMENT, INC., Boston Trust Walden Corp, Sofinnova Investments, Inc., among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.